Pneumon 2018, 31(4):205-206, Editorial
Seasonal Influenza Guidelines update
Authors Information
16th Department of Pneumonology, Hospital for Diseases of the Chest, “Sotiria”, Athens, 
2First Academic Department of Pneumonology, Interstitial Lung Diseases Unit, Hospital for Diseases of the Chest, “Sotiria”, Medical School, National and Kapodistrian University of Athens, Athens, Greece
  1. Jani AA, Uyeki TM. Chapter 46. Influenza. In: Emergency management of infectious diseases. 2nd ed. Chin RL, ed. Cambridge, UK: Cambridge University Press, 2018.
  2. Dimitroulis I, Katsaras M, Toumbis M. H1N1 infection and embolic events A multifaceted disease. Pneumon 2016; 29:230-35.
  3. Dimakakos E, Grapsa D, Vathiotis I, et al; H1N1-Induced Venous Thromboembolic Events? Results of a Single-Institution Case Series, Open Forum Infectious Diseases, Volume 3, Issue 4, 1 October 2016, ofw214, https://doi.org/10.1093/ofid/ofw214.
  4. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2017–18 influenza season. MMWR Recomm Rep 2017; 66:1-20.
  5. Uyeki T, Bernstein HH, Bradley SJ, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza (2018). Clinical Infectious Diseases 2018; pp. 1-47. DOI: 10.1093/cid/ciy866 [Epub ahead of print]
  6. Fiore EA, Fry A, Shay D, Gubareva L, Bresee SJ, Uyeki MT; Centers for Disease Control and Prevention (CDC). Recommendations and Reports “Antiviral agents for the treatment and chemoprophylaxis of influenza”. Influenza Division, National Center for Immunization and Respiratory Diseases 2011; 60:1-24.
  7. Hayden GF, Sugaya N, Hirotsu N, et al, for the Baloxavir Marboxil Investigators Group. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N Engl J Med 2018; 379:913-23. DOI: 10.1056/NEJMoa1716197.